Accelerated atherosclerosis in the transplant recipient: Role of hypertension

Journal of Human Hypertension

Volumn 12, Issue 12, 1998, Pages 851-854

  Fellstrom B ^a   Backman, U ^a   Larsson, E ^a   Wahlberg, J ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Chronic rejection; Hypertension; Myocardial infarction

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; MORTALITY; ORGAN TRANSPLANTATION; PATHOGENESIS; RISK FACTOR;

EID: 0032437645     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000712     Document Type: Article

References (35)

1. Raine AEG. Cardiovascular complications after renal transplantation. In: Morris PJ (ed). Kidney Transplantation, Principles and Practice. Saunders WB: London. 1988, pp 575-601.
2. Brunner FP et al. Survival on renal replacement therapy: data from the EDTA registry. Nephrol Dial Transplant 1988; 3: 109-122.
3. Kasiske BL et al. Cardiovascular disease after renal transplantation. JASN 1996; 7: 158-165.
4. Lindholm A et al. Ischemic heart disease - a major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60: 451-457.
5. Paul LC, Fellström B. Chronic vascular rejection of the heart and kidney. Have rational treatment options emerged? Transplantation 1992; 53: 1169-1179.
6. Fellström B, Larsson A. Pathogenesis and treatment perspectives in chronic graft rejection. Immunol Rev 1993; 134: 83-98.
7. Häyry P et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33-81.
8. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47: 1491-1499.
9. Kasiske BJ, Umen AJ. Persistent hyperlipidemia in renal transplant patients. Medicine 1987; 66: 309-316.
10. Vathsala et al. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 1989; 48: 37-43.
11. Dimeny E, Wahlberg J, Lithell H, Fellström B. Hyperlipidemia in renal transplantation - risk factor for long-term outcome. Eur J Clin Invest 1995; 25: 574-583.
12. Crisp SJ et al. Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease. J Heart Lung Transplant 1994; 13: 81-91.
13. Annuk M et al. Endothelium-dependent vasodilatation is impaired in renal disease. Manuscript.
14. Fellström B. Transplantation atherosclerosis. J Int Med 1996; 240: 253-257.
15. Almond PS et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752-756.
16. van Saase JLCM et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995; 59: 1280-1285.
17. Yilmaz S, Häyry P. The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 1993; 56: 1153-1156.
18. Wanders A et al. Ischemia induced transplant arteriosclerosis in the rat. Arterioscl Thromb Vasc Biol 1995; 15: 145-155.
19. Fellström B et al. Rapidly proliferative arteriopathy in cyclosporin-induced permanently surviving rat cardiac allografts simulating chronic vascular rejection. Clin Exp Immun 1990; 80: 288-292.
20. Dimeny E et al. The influence of pretransplant lipoprotein abnormalities on early results of renal transplant. Eur J Clin Inv 1993; 23: 572-579.
21. Ghanem H et al. Increased low density lipoprotein oxidation in stable kidney transplant recipients. Kidney Int 1996; 49: 448-493.
22. Lemström KB et al. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimai thickening of rat aortic allografts. J Clin Invest 1993; 92: 549-558.
23. Brenner BM, Milford EL. Nephron underdosing: A programmed cause of chronic renal allograft failure. Am J Kidney Dis 1993; 21 (Suppl): 66-72.
24. Heemann UW et al. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. Transplantation 1994; 58: 1317-1322.
25. Fellström B et al. Platelet-derived growth factor receptors in the kidney - Upregulated expression in inflammation. Kidney Int 1989; 36: 1099-1102.
26. Waltenberger J et al. Ischemia-induced transplant atherosclerosis in the rat. Induction of peptide growth factor expression. Arterioscl Thromb Vasc Proc 1996; 16: 1516-1523.
27. Waltenberger J et al. Induction of transforming growth factor β during cardiac allograft rejection. J Immunol 1993; 151: 1147-1157.
28. Van Ypersele de Sirihou C et al. Prevalence, etiology, and treatment of late posttransplant hypertension. In: Hamburger J et al (eds). Advances in Nephrology. Year Book Medical: Chicago, 1983, vol 12, pp 41-60.
29. Frei U et al. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction? Nephrol Dial Transplant 1995; 10: 1206-1211.
30. Cheigh JS et al. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 1989; 2: 341-348.
31. Sanders CE, Curtis JJ. Role of hypertension in chronic renal allograft dysfunction. Kidney Int 1995; 52: 43-47.
32. Modena FM et al. Progression of kidney disease in chronic renal transplant rejection. Transplantation 1991; 52: 239-244.
33. Ponticelli C et al. Hypertension after renal transplantation. Am J Kidney Dis 1993; 5 (Suppl 2): 73-78.
34. Opelz G et al. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 1998; 53: 217-222.
35. Paul LC, Benediktsson H. Post-transplant hypertension and chronic renal allograft failure. Kidney International Suppl 1995; 52: S34-S37.